Skip to main navigation Skip to search Skip to main content

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

*Corresponding author for this work
  • Amsterdam UMC
  • University of Oxford
  • Scripps Research Institute
  • University of Southampton
  • University of Amsterdam
  • All India Institute of Medical Sciences, New Delhi
  • Biomedical Primate Research Centre
  • Kumamoto University
  • Cornell University

Research output: Contribution to journalArticleAcademicpeer-review

29 Downloads (Pure)

Abstract

Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or single-chain Env designs can be expressed as native-like trimers, undesired monomers, dimers and malformed trimers that elicit non-neutralizing antibodies are also formed, implying that these designs could benefit from further modifications for gene-based vaccination approaches. Here, we describe the triple tandem trimer (TTT) design, in which three Env protomers are genetically linked in a single open reading frame and express as native-like trimers. Viral vectored Env TTT induced similar neutralization titers but with a higher proportion of trimer-specific responses. The TTT design was also applied to generate influenza hemagglutinin (HA) trimers without the need for trimerization domains. Additionally, we used TTT to generate well-folded chimeric Env and HA trimers that harbor protomers from three different strains. In summary, the TTT design is a useful platform for the design of HIV-1 Env and influenza HA immunogens for a multitude of vaccination strategies.
Original languageEnglish
Article number74
Journalnpj Vaccines
Volume9
Issue number1
DOIs
Publication statusPublished - 1 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines'. Together they form a unique fingerprint.

Cite this